INTRODUCTION
============

Atopic dermatitis (AD) is a chronic, relapsing and pruritic skin disease that occurs most commonly during early infancy and childhood. It is a multifactorial disease that is caused by the interaction of various factors, such as genetic background, allergic and immunologic abnormalities, pharmacologic and physiologic factors, environmental factors, and skin barrier defects. Its prevalence has recently been increasing at up to 10 to 20% of children and 1 to 3% of adults in industrialized countries[@B1].

Recent genetic studies have demonstrated that defective skin barrier function is an important factor in the pathogenesis of AD[@B2],[@B3]. Several studies have shown that transepidermal water loss (TEWL), which may represent skin barrier function, was increased in AD patients compared to those of the normal control group[@B4],[@B5].

On the other hand, the role of *Staphylococcus aureus* in the pathogenesis of AD is currently receiving attention. Actually, 90% of the skin of AD patients has shown colonization with *S. aureus*, and the number of *S. aureus* colonies in the sample from AD patients was significantly higher than those of normal controls[@B6]. Nasal colonization of *S. aureus* in infants with AD was also associated with the prevalence and clinical severity of AD[@B7].

The theory that the toxin produced by *S. aureus* exacerbates the disease activity of AD has been widely accepted, yet various rates of detecting toxin genes or commonly related genes have been reported by many researchers.

In the present study, we evaluated TEWL according to the clinical severity of AD, and we also examined the relationship between the clinical severity of AD and the colonization rates of *S. aureus* on the skin and the anterior nares. We also investigated the common toxin genes that are involved in the pathogenesis of AD in Korea.

MATERIALS AND METHODS
=====================

Study populations
-----------------

From June to August 2009, we acquired patients with AD and normal control group participants through an advertisement. All 39 patients with AD, according to the accepted diagnostic criteria in Korea[@B8], were enrolled and compared with healthy controls of a similar age (n=40). Those patients had no other systemic disease, no recent history of taking antibiotics and immunosuppressants for the month before the study, and no history of invasive infections, such as erysipelas and cellulitis. Voluntary informed consent in written form was obtained from all participants and/or legal guardians, and all the study protocols were reviewed and authorized by the Gil Hospital Institutional Review Board.

Scoring in atopic dermatitis (SCORAD) index
-------------------------------------------

The AD severity was assessed by using Severity Scoring of Atopic Dermatitis (SCORAD) index[@B9].

Measurement of TEWL
-------------------

TEWL was measured using a TEWAmeter TM210® (Courage & Khazaka, Cologne, Germany) for the evaluation of the skin barrier function. Before a measurement, the patient was made comfortable with exposing the examination site by sitting in a silent, draft-free, and direct light-free room at normal temperature for 10 minutes. The examination site was the most severe lesion, usually the antecubital area or popliteal fossa, as chosen by the same dermatologist who examined all the subjects. The measurement was performed for 1 minute.

Isolation of *S. aureus* from the skin and anterior nares
---------------------------------------------------------

To culture and separate *S. aureus*, we used transport media (Micromedia, Busan, Korea). The samples were taken from the antecubital area, the popliteal fossa, and the nasal mucosa, using sterile cotton tips. Within 24 hours, the sample was incubated on mannitol salt agar for 48 hours, and a single colony was pure-cultured and used for further experiments.

The identification of *S. aureus* was confirmed by a coagulase test and DNase test. We also performed multiplex polymerase chain reaction (PCR) to confirm the molecular identification of *S. aureus* and to check for methicillin-resistant *S. aureus*. The primers, including *nuc* and *mecA*, were provided by Sigma Genosys (Sydney, Australia), and they are shown in [Table 1](#T1){ref-type="table"}. DNA extraction was performed as follows: a single colony that had been incubated overnight was taken and added to 50 µl of proteinase K (100 mg/L; Sigma Genosys) and 150 µl of TE buffer (1 mM EDTA/10 mM Tris, pH 7.5). This was then incubated for 20 minutes at 37℃ and then at 95℃ for 5 minutes to deactivate the proteinase K. The suspension was centrifuged, and only the upper layer of the centrifuge tube was used for multiplex PCR. Multiplex PCR was performed on a Corbett Research PC-960 air-cooled thermocycler, using 50 µl of reaction mixture that included 1.25 U Amplitaq DNA polymerase (Perkin Elmer, Foster City, CA, USA), 200 µM dNTPs (Phamacia, Sydney, Australia), 20 ρmol primer, 1.5 mM MgCl~2~, 100 mM Tris-HCl (pH 8.3), 500 mM KCl, and 50 µl of DNA template. The extracted DNA was amplified for 30 cycles, and each cycle consisted of 60 s at 94℃ for denaturation, 30 s at 50℃ for annealing and 90 s at 72℃ for primer extension. Twenty microliter of PCR product was then analyzed by agarose gel electrophoresis (2% agarose prepared in TAE \[1 mM EDTA/40 mM Tris acetate, pH 8\] buffer). The gel was stained with ethidium bromide and photographed under ultraviolet light.

Detection of *S. aureus*-derived exotoxins
------------------------------------------

We performed multiplex PCR, as described by Breuer et al.[@B10], to detect the staphylococcal toxin genes carried by the *S. aureus* strains: staphylococcal enterotoxins *sea*, *seb*, *sec*, *sed*, and *see* and toxic shock syndrome toxin (*tsst*)-1. All primers were supplied by MWG Biotech (Ebersberg, Germany), and are shown in [Table 2](#T2){ref-type="table"}. A single colony was taken and suspended in 185 µl TE buffer (20 mM Tris chloride, 2 mM EDTA \[pH 8.0\]) with 15 µl of recombinant lysostaphin (15 mg/ml; AMBI, New York, NY, USA), and this was incubated at 37℃ for 30 minutes. The sample was subsequently extracted with a QIAamp tissue kit (QIAGEN, Hilden, Germany), according to the manufacturer\'s recommendations. Multiplex PCR was performed on an automated thermocycler with a hot bonnet (Hybaid, Teddington, UK), using a 50 µl reaction mixture that consisted of 1.25 U of Taq DNA polymerase (Boehringer, Mannheim, Germany), 200 µM of dATP, dCTP and dGTP, 600 µM UTP, 10 mM Tris-HCl (pH 8.9), 50 mM KCl, 3 mM MgCl~2~, 1.0 U of UNG and 0.5 ρmol of primer. The thermal cycling conditions for multiplex PCR were 30 cycles of denaturation at 95℃ for 1 minute (2 minutes for the first cycle), annealing at 55℃ for 1 minute and polymerization at 72℃ for 2 minutes (5 minutes for the final extension cycle). Ten microliter of the amplified products were analyzed by agarose gel electrophoresis.

Statistical analysis
--------------------

The statistical package for the social sciences (SPSS Version 12.0; SPSS Inc., Chicago, IL, USA) was used for all analyses. Chi-square tests were used to compare the *S. aureus* colonization rates between the AD patients and the normal controls. Kruskall-Wallis test was used to examine the correlation of TEWL, according to the number of colonization sites and the presence of nasal colonization. A *p*-value of less than 0.05 was defined as statistically significant.

RESULTS
=======

Characteristics of the subjects
-------------------------------

AD patients consisted of 18 males and 21 females (age: 1\~40 years, median: 11.8 years). We classified the SCORAD index as follows: less than 25 as mild, 25\~49 as moderate, and more than 50 as severe. The number of patients and their features are summarized in [Table 3](#T3){ref-type="table"}. The normal control group included 40 individuals (16 males and 24 females, age range: 1\~20 years, median age: 10 years).

Differences of TEWL according to clinical severity of AD
--------------------------------------------------------

The mean TEWL (g/m^2^ per hour), according to the severity of AD was 30.95 in mild, 37.00 in moderate, and 67.55 in severe patients. TEWL showed a statistically significant correlation with the clinical severity of AD ([Fig. 1](#F1){ref-type="fig"}, *p*=0.002).

Difference of *S. aureus* colonization rates between AD patients and normal controls
------------------------------------------------------------------------------------

Of the 39 patients, 25 patients (64.1%) had *S. aureus* on one or more sites of the skin. The mean colonization rates for AD patients were 25.6% on the antecubital area, 35.8% on the popliteal fossa, and 46.1% on the anterior nares. The overall mean colonization rate for the normal controls was 20%, and the anterior nares colonization rates of the normal controls were 17.5%. The results of the normal control subjects were lower than those of the AD patients, but the differences were not statistically significant ([Table 4](#T4){ref-type="table"}). Sixty-five percent of patients (13/20), who had *S. aureus* isolated from the anterior nares, also had *S. aureus* on the skin. Of 8 patients with *S. aureus* isolated from both the skin and anterior nares, 6 patients had the same toxins.

Differences of TEWL according to the number of *S. aureus* colonization sites in each of the severity groups
------------------------------------------------------------------------------------------------------------

For the relationship of TEWL and the number of colonization sites, we found that the greater the number of colonization sites, the higher the TEWL ([Fig. 2](#F2){ref-type="fig"}). However, this was not statistically significant (*p*\>0.05).

Differences of TEWL according to nasal colonization of *S. aureus* in each of the severity groups
-------------------------------------------------------------------------------------------------

For the relationship of TEWL and the colonization of the anterior nares, positive colonization of the anterior nares showed higher TEWL than the negative colonization in each of the groups ([Fig. 3](#F3){ref-type="fig"}). However, these were not statistically significant (*p*\>0.05).

Difference of colonization of *S. aureus* according to the SCORAD index of AD patients
--------------------------------------------------------------------------------------

For the relationship of colonization of *S. aureus* and the SCORAD index, we found that the higher SCORAD index group had more colonization of *S. aureus*. However, this was not statistically significant (*p*\>0.05, [Table 5](#T5){ref-type="table"}).

Toxin gene analysis of *S. aureus* in AD patients
-------------------------------------------------

*S. aureus* was isolated from 19 patients, and there were 32 total samples from the skin or the anterior nares. Among them, *nuc* was identified in all, except one sample, and *mecA* was not produced. Of the 19 patients with *S. aureus*, the predominant toxin gene was sea only in 10 patients, and the others were in co-existence with sea and *tsst-1* in 8 patients and *tsst-1* only in 1 patient ([Table 6](#T6){ref-type="table"}).

Of the 8 patients who had *S. aureus* on both the skin and nasal mucosa, 6 patients had the same toxin genes identified on both areas.

DISCUSSION
==========

The clinical expression of AD is the result of the complex interaction of environmental factors and skin barrier dysfunction, susceptibility genes, and immunologic abnormalities. In recent years, an impaired skin barrier function has been receiving attention as one of the important factors in the pathogenesis of AD. Normally, the skin barrier has roles as a permeability barrier, which guards against excessive water loss, and an immunologic barrier, which prevents the entry of harmful substances from the environment such as irritants, allergens, and micro-organisms[@B9]. However, a disturbed skin barrier causes the entry of various bacteria and viruses and hypersensitivity reactions, as well as abnormal immunologic reactions against micro-organisms and secondary infection[@B6],[@B9]. More than 90% of AD patients have *S. aureus* as the most common cutaneous infection. In contrast, *S. aureus* can be found on the skin of only 5% of healthy individuals[@B9],[@B10]. The increased level of *S. aureus* on AD patients is likely the result of combined processes, which includes altered lipid composition within the stratum corneum, exposed extracellular matrix adhesins, a defective immune response, bacterial superantigens, and increased specific immunoglobulin E production[@B9].

In our study, TEWL was significantly increased according to the clinical severity of AD. We also observed that TEWL was increased with an increased number of colonization sites in each of the clinical severity group, but this was not statistically significant. Through theses results, we can suggest that *S. aureus* colonization and damage of skin barrier function may be the important factors for the development and aggravation of AD.

Breuer et al.[@B11] cultured bacterial samples from the skin and nasal mucosa of adult AD patients, and they isolated *S. aureus* from 94% of AD patients. Of these patients, *S. aureus* was isolated on both the skin and nasal mucosa in 77.3%; however, 10.6% and 6.1% of AD patients had *S. aureus* isolated on the skin and nasal mucosa only, respectively. These results led to the hypothesis that the nose may be an important reservoir of *S. aureus* strains that are spread over the surface of the skin by autotransmission. They performed toxin gene analyses of *S. aureus* strains, isolated from the skin and anterior nares of 10 patients, and found that the nasal and cutaneous strains produced the same toxins in most cases, results which support this hypothesis.

In our results, *S. aureus* was isolated from 64.1% of AD patients (25/39), and this colonization rate was lower than the previously reported high colonization rates in atopic skin[@B11]. The reasons for lower colonization compared to other studies are geographical difference and a difference in the composition of the patients\' group\-- we included AD patients with less severe disease because we gathered the patients through an advertisement and did not include AD patients from the out-patient clinics. However, the colonization rate of *S. aureus* was strongly related to AD severity and the SCORAD index. We also observed that 65% of the patients (13/20) who had *S. aureus* isolated from the anterior nares also had *S. aureus* on the skin. Of the 8 patients with *S. aureus* isolated from both the skin and anterior nares, 6 had the same toxins; therefore, our results corresponded with those of Breuer et al.[@B11].

Indeed, *S. aureus* colonization is both a cause and a consequence of allergic skin inflammation in AD. Skin barrier dysfunction promotes increased *S. aureus* colonization; additionally, the exotoxins secreted by *S. aureus* are superantigens that are involved in the persistence and exacerbation of AD. Superantigens have several important distinguishing features that are different from the conventional peptide antigens in the pathogenesis of AD. The previously reported staphylococcal superantigens include *sea*, *seb*, *sec*, *sed*, *see*, *tsst-1*, and exfoliative toxins.

The most commonly used methods for assessing *S. aureus* toxins in the previous reports included reversed passive latex agglutination (RPLA) and multiplex PCR. In one study, ELISA had been used to separate the staphylococcal toxins, and the detection rate was 92%. The detection rates of RPLA had been reported to be 45.5%, 50%, and 67% in 3 different reports[@B12]-[@B14]. Yagi et al.[@B15] reported an 81% detection rate by PCR, and Kim et al.[@B14] also reported a 100% of detection rate by using a multiplex PCR in their study. Similar to Kim et al.[@B14], we also detected toxins in all the patients who were cultured for *S. aureus*. Zouharova and Rysanek[@B16] recently reported that multiplex PCR is a more useful tool for the detection of enterotoxin genes than RPLA. These results reflect that toxin gene assays by PCR are becoming more prevalent as a substitute for a latex test[@B14].

There are several reports about the colonization of *S. aureus* in AD in several countries ([Table 7](#T7){ref-type="table"})[@B12]-[@B18]. Each study reported various colonization rates of *S. aureus* and various dominant toxins of *S. aureus*. The difference in the predominant toxin carried by the *S. aureus* strains isolated from AD patients between the reports could be associated with different geographic regions[@B14]. In our study, the colonization rate was 64.1% (25/39), and *sea* was frequently detected. This result was similar to other studies on Korean people[@B14],[@B17]. We did not perform the assay for exfoliative toxins.

In conclusion, we ascertained the correlation between skin barrier function and the clinical severity of AD, and we observed that TEWL was increased with increasing colonization sites and positive colonization of the nasal mucosa in each clinical severity group. *S. aureus* was isolated from 64.1% of the AD patients (25/39). The rate of colonization of *S. aureus* was related to the SCORAD index. According to these results, we may assume that colonization of *S. aureus* and damage of skin barrier function may be important factors in the development and aggravation of AD. The colonization of *S. aureus* on the nasal mucosa was double that of the antecubital area and popliteal fossa, and 65% of AD patients with nasal colonization also showed colonization on the skin. In addition, the same toxins were detected in 6 of the 8 patients who had *S. aureus* on both the nasal mucosa and skin. These results imply that the nasal mucosa may be the major reservoir of *S. aureus* strains. The most common toxin gene was *sea* in our Korean AD patients, which is similar to that of other studies performed in Korea. Therefore, *sea* may be an important factor in the pathogenesis of AD in Korean patients, and further investigation should be done on the role of superantigens in the pathogenesis in AD.
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Primers for *nuc* and *mecA*
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PCR: polymerase chain reaction.

###### 

Base sequences and the predicted sizes of the PCR products for the *Staphylococcus aureus* exotoxin-specific oligonucleotiede primers
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PCR: polymerase chain reaction.
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Characteristics of AD and non-AD control
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AD: atopic dermatitis, SCORAD: Severity Scoring of Atopic Dermatitis, NA: not applicable.
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Frequency of *Staphylococcus aureus* colonization on the AD patients and normal controls
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Values are presented as number (%). *p*\>0.05 as measured by the Chi-square test. AD: atopic dermatitis.
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*Staphylococcus aureus* colonization according to the severity of AD
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Values are presented as number (%). *p*\>0.05 as measured by the Chi-square test. AD: atopic dermatitis, SCORAD: Severity Scoring of Atopic Dermatitis.
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Detection rates of staphylococcal toxin genes from the AD patients with *Staphylococcus aureus* isolates
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Values are presented as number (%). *Sea*: staphylococcal enterotoxin a, *tsst-1*: toxic shock syndrome toxin-1.
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Reference about *Staphylococcus aureus* colonization

![](ad-24-413-i007)
